Speculations on why early treatment of rheumatoid arthritis is uniquely effective

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2090-2093

  Sharp, John T ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BETAMETHASONE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ACTIVITY; DISEASE COURSE; DRUG MEGADOSE; EARLY INTERVENTION; EDITORIAL; HUMAN; LOW DRUG DOSE; MONOTHERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; REMISSION INDUCTION;

EID: 56449114758     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080671     Document Type: Editorial

References (22)

1. Jones LR. Arthritis deformans: comprising rheumatoid arthritis, osteo-arthritis, and spondylitis deformans. New York: William Wood; 1909.
2. Fraser TN. Gold treatment in rheumatoid arthritis. Ann Rheum Dis 1945;4:71-5.
3. Lewis-Fanning E, Fletcher E. A statistical study of 1,000 cases of chronic rheumatism. Post Grad M J 1945;21:137-46,176-85.
4. Short CL, Bauer W, Reynolds WE. Rheumatoid arthritis: a definition of the disease and a description based on a numerical study of 293 patients and controls. Cambridge: Harvard University Press; 1957.
5. Mottonen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo Trial Group. Lancet 1999;353:1568-73.
6. Korpela M, Laasonen L, Hannonen P, et al; FIN-RACo Trial Group. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072-81.
7. O'Dell JR, Leff R, Paulsen G, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications. Arthritis Rheum 2002;46:1164-70.
8. Eberhardt K, Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years. Br J Rheumatol 1998;37:1324-9.
9. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54:1401-9.
10. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
11. St. Clair EW, van der Heijde DMFM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
12. Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER Study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
13. Smolen JS, Aletaha D, Keystone E. Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction? Arthritis Rheum 2005;52:2975-83.
14. van der Helm-van Mil AH, le Cessie S, van Dongen H, et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007;56:433-40.
15. Boers M, Verhoeven AC, Markusse HM, et al.Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1998;351:220.
16. Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
17. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). Arthritis Rheum 2005;52:3381-91.
18. Quinn MA, Conaghan PG, O'Connor PJ, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35.
19. Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Sledge CB. Kelley's textbook of rheumatology. Philadelphia: WB Saunders; 2004.
20. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4th ed. Edinburgh: Mosby-Elsevier; Springer; 2008.
21. Koopman WJ, Moreland LW. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lippincott Williams & Wilkins; 2005.
22. White PD. Heart disease. 3rd ed. New York: MacMillan; 1944:324.